Aster DM Healthcare plans to increase its stake in Malabar Institute of Medical Sciences (MIMS) by acquiring an additional 20.25% of equity shares. This move aims to consolidate Aster DM Healthcare’s shareholding in MIMS from 79.75% to 100%. The transaction will be executed through a purchase of shares from existing shareholders, with completion expected within 3 months.
Strategic Acquisition of MIMS Shares
Aster DM Healthcare’s Investment and Finance Committee has approved a proposal to acquire additional equity shares in its material subsidiary, Malabar Institute of Medical Sciences Limited (MIMS). The decision, made on January 29, 2026, aims to consolidate the company’s position in MIMS.
Deal Structure and Rationale
The acquisition involves purchasing an aggregate of 20.25% of MIMS’s equity share capital from its existing shareholders. This will increase Aster DM Healthcare’s total ownership to 100% from the current 79.75%. The terms and conditions are detailed in a letter of offer to the shareholders. The proposed acquisition will be a cash consideration deal.
MIMS Overview
Malabar Institute of Medical Sciences (MIMS), established on February 17, 1995, operates exclusively in India. It is focused on providing healthcare services, particularly running hospitals. As of March 31, 2025, MIMS reported a turnover of INR 1,118.05 crores and a profit of INR 134.51 crores. The turnover figures for the previous years are as follows:
Turnover figures:
- 2025: INR 1,118.05 Cr
- 2024: INR 1,014.36 Cr
- 2023: INR 899.43 Cr
Timeline for Completion
The letter of offer is expected to be dispatched to the shareholders of MIMS soon, and the transaction is anticipated to be completed within 3 months from the dispatch date.
Source: BSE
